FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

S Chumpradit

Research Profile

Living Beings

Chemicals & Drugs

Concepts & Ideas

Tissue Distribution

Anatomy

Brain

Procedures

Physiology

Binding, Competitive

Co-author Network

Publications

TOP 3
Seok-Rye Choi; B Yang; Karl Plössl; S Chumpradit; Shiaw-Pyng Wey; Paul D Acton; K Wheeler; R H Mach; Hank F Kung
Development of a Tc-99m labeled sigma-2 receptor-specific ligand as a potential breast tumor imaging agent.
JM Vessotskie; Mei-Ping Kung; S Chumpradit; Hank F Kung
Quantitative autoradiographic studies of dopamine D3 receptors in rat cerebellum using [125I]S(-)5-OH-PIPAT.
JM Vessotskie; Mei-Ping Kung; S Chumpradit; Hank F Kung
Characterization of [125I]S(-)5-OH-PIPAT binding to dopamine D2-like receptors expressed in cell lines.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of S Chumpradit (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2001: Seok-Rye Choi; B Yang; Karl Plössl; S Chumpradit; Shiaw-Pyng Wey; Paul D Acton; K Wheeler; R H Mach; Hank F Kung
Development of a Tc-99m labeled sigma-2 receptor-specific ligand as a potential breast tumor imaging agent.
Nuclear medicine and biology 2001;28(6):657-66.
1997: JM Vessotskie; Mei-Ping Kung; S Chumpradit; Hank F Kung
Quantitative autoradiographic studies of dopamine D3 receptors in rat cerebellum using [125I]S(-)5-OH-PIPAT.
Brain research 1997;778(1):89-98.
1997: JM Vessotskie; Mei-Ping Kung; S Chumpradit; Hank F Kung
Characterization of [125I]S(-)5-OH-PIPAT binding to dopamine D2-like receptors expressed in cell lines.
Neuropharmacology 1997;36(7):999-1007.
1997: SK Meegalla; Karl Plössl; Mei-Ping Kung; S Chumpradit; DA Stevenson; SA Kushner; WT McElgin; P David Mozley; Hank F Kung
Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents.
Journal of medicinal chemistry 1997;40(1):9-17.
1997: Mei-Ping Kung; DA Stevenson; Zhi-Ping Zhuang; JM Vessotskie; S Chumpradit; X M Sun; Hank F Kung
Characterization of a novel iodinated ligand, IPMPP, for human dopamine D4 receptors expressed in CHO cells.
Life sciences 1997;60(2):91-100.
1996: SK Meegalla; Karl Plössl; Mei-Ping Kung; S Chumpradit; DA Stevenson; D Frederick; Hank F Kung
Tc-99m-labeled tropanes as dopamine transporter imaging agents.
Bioconjugate chemistry 1996;7(4):421-9.
1995: P David Mozley; J B Stubbs; H J Kim; W McElgin; S Chumpradit; Mei-Ping Kung; G Romaniello; Hank F Kung
Dosimetry of a D2/D3 dopamine receptor antagonist that can be used with PET or SPECT.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(7):1322-31.
1995: JM Vessotskie; Mei-Ping Kung; S Chumpradit; G Romaniello; W McElgin; D Frederick; Robert T Malison; Hank F Kung
In vitro and in vivo characterization of R(+)-FIDA2: a dopamine D2-like imaging agent.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(7):1282-8.
1994: Zhi-Ping Zhuang; Mei-Ping Kung; S Chumpradit; M Mu; Hank F Kung
Derivatives of 4-(2'-methoxyphenyl)-1-[2'-(N-2"-pyridinyl-p-iodobenzamido)ethyl]pipera zine (p-MPPI) as 5-HT1A ligands.
Journal of medicinal chemistry 1994;37(26):4572-5.
1994: Mei-Ping Kung; S Chumpradit; D Frederick; S Garner; K D Burris; P B Molinoff; Hank F Kung
Characterization of binding sites for [125I]R(+)trans-7-OH-PIPAT in rat brain.
Naunyn-Schmiedeberg's archives of pharmacology 1994;350(6):611-7.
1994: S Chumpradit; Mei-Ping Kung; JM Vessotskie; C Foulon; M Mu; Hank F Kung
Iodinated 2-aminotetralins and 3-amino-1-benzopyrans: ligands for dopamine D2 and D3 receptors.
Journal of medicinal chemistry 1994;37(24):4245-50.
1994: K D Burris; T M Filtz; S Chumpradit; Mei-Ping Kung; C Foulon; Julie Hensler; Hank F Kung; P B Molinoff
Characterization of [125I](R)-trans-7-hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino] tetralin binding to dopamine D3 receptors in rat olfactory tubercle.
The Journal of pharmacology and experimental therapeutics 1994;268(2):935-42.
1994: S E Garner; Mei-Ping Kung; C Foulon; S Chumpradit; Hank F Kung
[125I](S)-trans-7-OH-PIPAT: a potential spect imaging agent for sigma binding sites.
Life sciences 1994;54(9):593-603.
1993: S Chumpradit; Mei-Ping Kung; Hank F Kung
Synthesis and optical resolution of (R)- and (S)-trans-7-Hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino]tetralin: a new D3 dopamine receptor ligand.
Journal of medicinal chemistry 1993;36(26):4308-12.
1993: Mei-Ping Kung; Hank F Kung; S Chumpradit; C Foulon
In vitro binding of a novel dopamine D3 receptor ligand: [125I]trans-7-OH-PIPAT-A.
European journal of pharmacology 1993;235(1):165-6.
1993: S Chumpradit; Mei-Ping Kung; J Billings; Robert H Mach; Hank F Kung
Fluorinated and iodinated dopamine agents: D2 imaging agents for PET and SPECT.
Journal of medicinal chemistry 1993;36(2):221-8.
1992: S Chumpradit; Mei-Ping Kung; C Panyachotipun; V Prapansiri; C Foulon; B P Brooks; S A Szabo; Shanaz Tejani-Butt; Alan Frazer; Hank F Kung
Iodinated tomoxetine derivatives as selective ligands for serotonin and norepinephrine uptake sites.
Journal of medicinal chemistry 1992;35(23):4492-7.
1992: Mei-Ping Kung; S Chumpradit; J Billings; H Kung
4-Iodotomoxetine: a novel ligand for serotonin uptake sites.
Life sciences 1992;51(2):95-106.
1992: J J Billings; Mei-Ping Kung; S Chumpradit; D Mozley; Abass Alavi; Hank F Kung
Characterization of radioiodinated TISCH: a high-affinity and selective ligand for mapping CNS D1 dopamine receptor.
Journal of neurochemistry 1992;58(1):227-36.
1991: S Chumpradit; Mei-Ping Kung; J J Billings; Hank F Kung
Synthesis and resolution of (+-)-7-chloro-8-hydroxy-1-(3'-iodophenyl)-3-methyl-2,3,4,5-tetrahydro- 1H-3- benzazepine (TISCH): a high affinity and selective iodinated ligand for CNS D1 dopamine receptor.
Journal of medicinal chemistry 1991;34(3):877-83.
1990: T M Filtz; S Chumpradit; Hank F Kung; P B Molinoff
Synthesis and applications of an aldehyde-containing analogue of SCH-23390.
Bioconjugate chemistry 1990;1(6):394-9.
1989: S Chumpradit; Hank F Kung; J Billings; Mei-Ping Kung; S Pan
(+/-)-7-chloro-8-hydroxy-1-(4'-[125I]iodophenyl)-3-methyl-2,3,4,5- tetrahydro-1H-3-benzazepine: a potential CNS D-1 dopamine receptor imaging agent.
Journal of medicinal chemistry 1989;32(7):1431-5.
1989: S Chumpradit; Hank F Kung; J Billings; Y Z Guo; Y Wu; J Shih
Preparation and biodistribution of 1-[2-(3-[125I]iodo-4-aminophenyl)ethyl]-4-[3-(trifluoromethyl) phenyl]piperazine and 1-[2-(3-[125I]iodo-4-azidophenyl)ethyl]-4-[3-(trifluoromethyl)phenyl] piperazine.
Journal of medicinal chemistry 1989;32(3):543-7.
1989: J Billings; Mei-Ping Kung; S Chumpradit; S Pan; Hank F Kung
[125I](+/-)FISCH: a new CNS D-1 dopamine receptor imaging ligand.
Life sciences 1989;45(8):711-8.